THE OFFICIAL NEWS SOURCE OF ACR CONVERGENCE 2022 • NOVEMBER 10-14
-
Plenary II details data on biosimilar switching, co-pays, and other new research
The second of three plenary sessions addressed ground-breaking developments in rheumatic diseases, including Sjögren’s syndrome, systemic sclerosis, lupus, and osteoarthritis. Raisa Lomanto Silva, MD, discussed drug co-pay costs and adherence. READ MORE
-
Rheumatologists can help young patients to preserve their reproductive health
Children with rheumatic disease often become adults with rheumatic disease. Cuoghi Edens, MD, FAAP, and Jacqueline Maher, MD, discussed how rheumatology providers can support reproductive health and protect fertility in adolescent patients. READ MORE
-
Experts offer guidance on contraception safety, legal risks in reproductive health session
Panelists including Megan Clowse, MD, MPH, offered practical guidance and tools for discussing contraception and family planning with rheumatology patients. She encouraged honest, accurate conversation, as well as creating an environment of trust and safety. READ MORE
-
Open communication facilitates dignity and respect in care of gender-diverse patients
Many transgender and non-binary patients avoid seeking care because of the discrimination they have faced in the clinic. This lack of care can lead to chronic health issues, said Nathan Levitt, FNP-BC, MSN, RN, BSN, MA, in a session on strategies for improving the clinical experience for this population. READ MORE
-
Experts debate the role of DMARDs in subclinical RA
During this year’s Great Debate, experts including Janet Pope, MD, MPH, FRCPC, and Hani El-Gabalawy, MD, FRCPC, reviewed the data on subclinical disease and the risk of progression to rheumatoid arthritis, presenting arguments for and against starting a DMARD in this challenging clinical scenario. READ MORE
-
Kristin Wipfler, PhD: Impact on Access to Methotrexate in the Post-Roe Era
Kristin Wipfler, PhD, will discuss the poster “Impact on Access to Methotrexate in the Post-Roe Era” in a Monday afternoon Ignite Talk. READ MORE
-
Matthew C. Baker, MD, MS: Sarcoidosis Incidence after mTOR Inhibitor Treatment
Kristin Wipfler, PhD, will discuss the poster “Impact on Access to Methotrexate in the Post-Roe Era” in a Monday afternoon Ignite Talk. READ MORE
-
Robert M. Hamilton, MD, MHSc, FRCP(C): Fetal Cardiac Targets Identify the Autoantibodies Associated with Congenital Heart Block
Robert M. Hamilton, MD, MHSc, FRCP(C), will discuss the poster “Fetal Cardiac Targets Identify the Autoantibodies Associated with Congenital Heart Block” in a Monday afternoon Ignite Talk. READ MORE
-
Sabine Sparre Dieperink, MD: The Increased Risk of Staphylococcus Aureus Bacteremia in Rheumatoid Arthritis – What Is the Impact of Glucocorticoids, Biologic Disease-Modifying Anti-Rheumatic Drugs and Disease Activity: A Danish Nationwide Nested Case-Control Study in the DANBIO Registry
Sabine Sparre Dieperink, MD, will discuss the poster “The Increased Risk of Staphylococcus Aureus Bacteremia in Rheumatoid Arthritis – What Is the Impact of Glucocorticoids, Biologic Disease-Modifying Anti-Rheumatic Drugs and Disease Activity: A Danish Nationwide Nested Case-Control Study in the DANBIO Regis” in a Monday afternoon Ignite Talk. READ MORE
-
Daltroy lecturer to illustrate potential of social media to enhance patient education and care
Cheryl Crow, OT, will deliver the Daltroy Lecture in a talk show format. Drawing on her professional experience as an occupational therapist and her personal experience living with rheumatoid arthritis, she will discuss how social media usage can benefit health management and the psychosocial well-being of patients. READ MORE